Application 021455
- Type
- NDA
- Sponsor
- HOFFMANN LA ROCHE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BONIVA | IBANDRONATE SODIUM | TABLET;ORAL | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 002 | BONIVA | IBANDRONATE SODIUM | TABLET;ORAL | EQ 150MG BASE | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021455-001 | BONIVA | IBANDRONATE SODIUM | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2003-05-16 | |
| N021455-002 | BONIVA | IBANDRONATE SODIUM | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-24 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N021455-001 | BONIVA | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2003-05-16 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N021455-002 | BONIVA | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-24 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021455-001 | BONIVA | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2003-05-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021455-002 | BONIVA | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-24 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021455-001 | BONIVA | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2003-05-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021455-002 | BONIVA | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-24 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021455-001 | BONIVA | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2003-05-16 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021455-002 | BONIVA | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-24 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021455-001 | BONIVA | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2003-05-16 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021455-002 | BONIVA | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-24 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021455-001 | BONIVA | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2003-05-16 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021455-002 | BONIVA | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-24 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021455-001 | BONIVA | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2003-05-16 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021455-002 | BONIVA | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-24 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021455-001 | BONIVA | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2003-05-16 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021455-002 | BONIVA | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-24 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021455-001 | BONIVA | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2003-05-16 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021455-002 | BONIVA | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-24 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021455-001 | BONIVA | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2003-05-16 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021455-002 | BONIVA | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-24 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021455-001 | BONIVA | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2003-05-16 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021455-002 | BONIVA | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-24 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021455-001 | BONIVA | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2003-05-16 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021455-002 | BONIVA | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-24 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021455-001 | BONIVA | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2003-05-16 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021455-002 | BONIVA | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-24 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021455-001 | BONIVA | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2003-05-16 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021455-002 | BONIVA | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-24 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021455-001 | BONIVA | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2003-05-16 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021455-002 | BONIVA | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2005-03-24 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021455-001 | BONIVA | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2003-05-16 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021455-002 | BONIVA | EQ 150MG BASE | TABLET / ORAL | RLD | 2005-03-24 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021455-001 | BONIVA | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2003-05-16 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021455-002 | BONIVA | EQ 150MG BASE | TABLET / ORAL | RLD | 2005-03-24 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021455-001 | BONIVA | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2003-05-16 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021455-002 | BONIVA | EQ 150MG BASE | TABLET / ORAL | RLD | 2005-03-24 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021455-001 | BONIVA | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 2003-05-16 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021455-002 | BONIVA | EQ 150MG BASE | TABLET / ORAL | AB | RLD, RS | 2005-03-24 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N021455-001 | BONIVA | EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 2003-05-16 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021455-002 | BONIVA | EQ 150MG BASE | TABLET / ORAL | RLD | 2005-03-24 | bb7c543d1eb4… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N021455-002 | AB | 1 | 74a2ff9319b5… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021455-002 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N021455-002 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N021455-002 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N021455-002 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N021455-002 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N021455-002 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N021455-002 | AB | 1 | ea99ee380514… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021455-002 | 7192938 | 2023-05-06 | U-798 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021455-002 | 7410957 | 2023-05-06 | U-887 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021455-002 | 7718634 | 2023-05-06 | U-642 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021455-002 | 7192938 | 2023-05-06 | U-798 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021455-002 | 7410957 | 2023-05-06 | U-887 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021455-002 | 7718634 | 2023-05-06 | U-642 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N021455-002 | 7192938 | 2023-05-06 | U-798 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N021455-002 | 7410957 | 2023-05-06 | U-887 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N021455-002 | 7718634 | 2023-05-06 | U-642 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021455-001 | 6294196 | 2019-10-07 | Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021455-002 | 6294196 | 2019-10-07 | Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021455-002 | 7192938 | 2023-05-06 | U-798 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021455-002 | 7410957 | 2023-05-06 | U-887 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021455-002 | 7718634 | 2023-05-06 | U-642 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N021455-002 | 7192938 | 2023-05-06 | U-798 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N021455-002 | 7410957 | 2023-05-06 | U-887 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N021455-002 | 7718634 | 2023-05-06 | U-642 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N021455-002 | 7192938 | 2023-05-06 | U-798 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N021455-002 | 7410957 | 2023-05-06 | U-887 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N021455-002 | 7718634 | 2023-05-06 | U-642 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021455-002 | 7192938 | 2023-05-06 | U-798 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021455-002 | 7410957 | 2023-05-06 | U-887 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021455-002 | 7718634 | 2023-05-06 | U-642 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N021455-002 | 7192938 | 2023-05-06 | U-798 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N021455-002 | 7410957 | 2023-05-06 | U-887 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N021455-002 | 7718634 | 2023-05-06 | U-642 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021455-002 | 7192938 | 2023-05-06 | U-798 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021455-002 | 7410957 | 2023-05-06 | U-887 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021455-002 | 7718634 | 2023-05-06 | U-642 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021455-002 | 7192938 | 2023-05-06 | U-798 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021455-002 | 7410957 | 2023-05-06 | U-887 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021455-002 | 7718634 | 2023-05-06 | U-642 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021455-001 | 6294196 | 2019-10-07 | Drug product | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021455-002 | 6294196 | 2019-10-07 | Drug product | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021455-002 | 7192938 | 2023-05-06 | U-798 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021455-002 | 7410957 | 2023-05-06 | U-887 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021455-002 | 7718634 | 2023-05-06 | U-642 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N021455-001 | 6294196 | 2019-10-07 | Drug product | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N021455-002 | 6294196 | 2019-10-07 | Drug product | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N021455-002 | 7192938 | 2023-05-06 | U-798 | b00525d2431f… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibandronate Sodium | IBANDRONATE SODIUM | Aurobindo Pharma Limited | 86c0b4ae-5e38-4efe-88af-50ac560e294f | 2026-03-18 | Warnings, Adverse reactions | IBANDRONATE SODIUM |
| IBANDRONATE SODIUM | IBANDRONATE SODIUM | Sun Pharmaceutical Industries, Inc. | be514be6-727a-4d6c-993b-52144f8e6de8 | 2026-03-03 | Warnings, Adverse reactions | IBANDRONATE SODIUM |
| IBANDRONATE SODIUM | IBANDRONATE SODIUM | Golden State Medical Supply, Inc. | 618e1aff-ccbb-4cee-93f1-fe04e33dacb7 | 2026-02-19 | Warnings, Adverse reactions | IBANDRONATE SODIUM |
| Ibandronate sodium | IBANDRONATE SODIUM | Dr. Reddy's Laboratories Limited | f94d9c49-245a-8081-42c4-785113fce498 | 2026-02-16 | Warnings, Adverse reactions | IBANDRONATE SODIUM |
| Ibandronate Sodium | IBANDRONATE SODIUM | Eugia US LLC | e81f2c5b-bead-48ac-be3e-016cf963d7ed | 2026-01-27 | Warnings, Adverse reactions | IBANDRONATE SODIUM |
| IBANDRONATE SODIUM | IBANDRONATE SODIUM | Macleods Pharmaceuticals Limited | a5741ef6-0599-4657-8cda-2902ded4f680 | 2026-01-19 | Warnings, Adverse reactions | IBANDRONATE SODIUM |
| Ibandronate Sodium | IBANDRONATE SODIUM | Apotex Corp. | 9fad4982-95af-d711-f50a-867311835143 | 2026-01-15 | Warnings, Adverse reactions | IBANDRONATE SODIUM |
| Ibandronate sodium | IBANDRONATE SODIUM | A-S Medication Solutions | e5b6c2a9-a55f-41f9-a592-e26ef03e2d73 | 2025-09-22 | Warnings, Adverse reactions | IBANDRONATE SODIUM |
| IBANDRONATE SODIUM | IBANDRONATE SODIUM | Bionpharma Inc. | 6ca94cce-a2bb-421f-bd8f-6b14bc2bd985 | 2023-05-23 | Warnings, Adverse reactions | IBANDRONATE SODIUM |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0004-0186 | Boniva | ibandronate sodium | Genentech, Inc. | NDA | Current |
| 0004-0186 | Boniva | ibandronate sodium | Genentech, Inc. | NDA | Current |
| 0004-0186 | Boniva | ibandronate sodium | Genentech, Inc. | NDA | Current |
| 0004-0186 | Boniva | ibandronate sodium | Genentech, Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 46098 | SUPPL | 2016-12-08 |
| 46097 | SUPPL | 2016-12-08 |
| 46095 | SUPPL | 2016-12-07 |
| 5441 | SUPPL | 2015-04-13 |
| 36983 | SUPPL | 2015-04-10 |
| 15523 | SUPPL | 2015-03-24 |
| 27846 | SUPPL | 2015-03-19 |
| 42177 | SUPPL | 2015-03-11 |
| 36982 | SUPPL | 2014-12-19 |
| 27845 | SUPPL | 2014-12-18 |
| 27844 | SUPPL | 2013-04-24 |
| 5440 | SUPPL | 2013-04-24 |
| 36981 | SUPPL | 2013-04-23 |
| 15522 | SUPPL | 2013-04-23 |
| 27843 | SUPPL | 2011-07-06 |
| 27842 | SUPPL | 2011-02-02 |
| 15521 | SUPPL | 2011-01-31 |
| 5439 | SUPPL | 2010-01-15 |
| 15520 | SUPPL | 2010-01-08 |
| 27841 | SUPPL | 2008-11-28 |
| 27840 | SUPPL | 2007-02-23 |
| 15519 | SUPPL | 2007-02-21 |
| 5438 | SUPPL | 2006-06-20 |
| 5437 | SUPPL | 2005-03-28 |
| 23072 | SUPPL | 2005-03-25 |
| 15518 | SUPPL | 2005-03-25 |
| 44125 | ORIG | 2003-12-09 |
| 42176 | ORIG | 2003-07-02 |
| 5436 | ORIG | 2003-06-08 |
| 15517 | ORIG | 2003-05-29 |